Partnering With Antenatal Navigators to Transform Health in Pregnancy
PATH
2 other identifiers
interventional
600
1 country
1
Brief Summary
The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Patient navigation is an individualized, barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. In this randomized controlled trial, pregnant women who are randomized to receive antenatal patient navigation will be compared to pregnant women who are randomized to receive usual care. Navigators will support pregnant women from before 20 weeks of gestation through 2 weeks postpartum. The PATH intervention will be grounded in understanding and addressing factors that influence health and access to care in order to promote self-efficacy, enhance access, and sustain long-term engagement. The main objectives of the study are to:
- 1.Evaluate whether PATH, compared to usual care, improves maternal health outcomes. We hypothesize the PATH model of antenatal patient navigation for low-income women will reduce the incidence of a composite of adverse maternal outcomes, all of which are known to be increased among women with barriers to care.
- 2.Evaluate whether PATH, compared to usual care, improves perinatal health outcomes. We hypothesize PATH will reduce the incidence of a composite of adverse perinatal outcomes. We will also investigate neonatal/pediatric health care utilization.
- 3.Evaluate patient, clinician, navigator, and healthcare system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim will be accomplished through investigating patient-reported outcomes, completing qualitative and process mapping interviews with navigated participants, and completing qualitative and process mapping interviews with clinicians, navigators, and health administrators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 24, 2025
CompletedStudy Start
First participant enrolled
October 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
October 9, 2025
October 1, 2025
3.6 years
April 11, 2025
October 8, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Maternal adverse outcome composite (Aim 1 primary outcome)
Frequency of maternal composite, which includes hypertensive disorders of pregnancy, preterm birth, postpartum hemorrhage, severe maternal morbidity, or maternal mortality. Components of the primary outcome will also be examined as a score and individually as secondary outcomes (see below).
Enrollment through delivery hospitalization, an average of 28 weeks
Neonatal adverse outcome composite (Aim 2 primary outcome)
Frequency of the neonatal composite, which includes neonatal intensive care unit (NICU) admission, low birthweight, small-for-gestational-age (SGA), large-for-gestational-age (LGA) status, and/or perinatal death. Components of the composite outcome will also be examined as a score and individually as secondary outcomes (see below).
At birth/delivery
Secondary Outcomes (27)
Hypertensive disorder of pregnancy (component of primary outcome)
Enrollment through delivery hospitalization, an average of 28 weeks
Preterm birth (component of primary outcome)
Enrollment through delivery hospitalization, an average of 28 weeks
Postpartum hemorrhage (component of primary outcome)
At birth/delivery
Severe maternal morbidity (component of primary outcome)
Enrollment through delivery hospitalization, an average of 28 weeks
Maternal mortality (component of primary outcome)
Enrollment through delivery hospitalization, an average of 28 weeks
- +22 more secondary outcomes
Other Outcomes (5)
Participant experiences with patient navigation and antenatal care process mapping
Enrollment through delivery hospitalization, an average of 28 weeks
Satisfaction with navigation (interpersonal aspects)
During pregnancy and through 9 months postpartum
Satisfaction with navigation (logistical aspects)
During pregnancy and through 9 months postpartum
- +2 more other outcomes
Study Arms (2)
Navigation Group
EXPERIMENTALPregnant participants who are randomized to receive PATH patient navigation will be assigned to a patient navigator. The patient navigator will meet with the patient in early pregnancy for introductions, education, and assessing factors that influence health and access to care. The patient navigator will offer support and resources (e.g., appointment coordination and scheduling, communication with clinical team, transportation, community referrals, support for mental health, support for other non-medical needs, etc.). The navigator will provide support and continue linkage to resources through 2 weeks postpartum.
Non-navigation Group
NO INTERVENTIONNo navigation will be provided; pregnant participants will receive usual care.
Interventions
PATH navigation is an antenatal patient navigator program designed to reduce barriers to care, enhance access, improve self-efficacy and knowledge, and improve multiple perinatal health outcomes. PATH navigation is a flexible, multi-pronged, patient-centered program with the capacity to evolve with patient needs and preferences. Early in pregnancy, navigators will establish themselves as a non-medical resource and will introduce PATH as a program designed to help inform, support, and connect patients during pregnancy. Navigators will review screen and address supportive and adverse non-medical needs, facilitate communication, perform logistical support, provide advocacy and bridge communication with clinical teams, and perform health education. Navigation services will be tailored to individual medical, psychosocial, or logistical complexity.
Eligibility Criteria
You may qualify if:
- Singleton gestation \<20 weeks of gestation
- Nulliparous: no prior pregnancies ≥20 weeks excluding terminations
- Low income (public insurance or residence in a neighborhood in which \>10% of household incomes are \<125% of federal poverty line
- Ability to speak and read English or Spanish
- Established patient at one of practices associated with Northwestern Medical Group
- Age 16 years or older
You may not qualify if:
- Intent to transfer care to an outside institution
- Prior enrollment in PATH
- Concurrent enrollment in a study with competing aims/intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lynn M Yee, MD, MPH
Northwestern University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 24, 2025
Study Start
October 6, 2025
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
October 9, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share